Funder
Millenium
National Cancer Institute
Novartis Pharma
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference23 articles.
1. Pishvaian M, Marshall JL, He R, Wang D (2011) Epidermal growth factor inhibitors. In: Schwab M (ed) Encyclopedia of cancer. Springer, Berlin
2. Marshall J (2006) Clinical implications of the mechanism of epidermal growth factor receptor inhibitors. Cancer 107:1207–1218
3. Tykerb [package insert]. Novartis, 2013
4. Opdam FL, Guchelaar HJ, Beijnen JH, Schellens JH (2012) Lapatinib for advanced or metastatic breast cancer. Oncologist 17(4):536–542
5. Wisinski KB, Tevaarwek AJ, Burkard ME et al (2016) Phase I Study of an AKT inhibitor (MK-2206) combined with lapatinib in adults solid tumors followed by dose expansion in advanced HER2 + breast cancer. Clin Cancer Res 22(11):2659–2667
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献